Model
We are not claiming venture capital was wrong. We are observing that the scarce factor changed. Capital was valuable because it was scarce relative to the bottleneck. The bottleneck is no longer money.
The venture model was never irrational. It was the rational answer to one specific scarcity: scaling cost people.
More revenue meant more sales, more support, more engineering, more operations. Capital was the lever that bought those people ahead of the revenue, and whoever bought first took the market. The investor was never selling money. The investor was selling time.
Where compute does the scaling work — code, support, content, analysis, sales preparation — the equation changes. Compute scales with revenue, not ahead of it. It is a variable cost tied to usage, not a block of spending to be financed in advance.
| Dimension | When labour was scarce | When compute does the work |
|---|---|---|
| Cost of scaling | Linear in people, fixed, upfront | Variable, with revenue |
| Need for capital | Structural | Optional |
| What the investor sells | Time bought ahead of revenue | Access and judgement |
| What decides | Size of the fund | Quality of the access |
If a company can fund itself and still takes dilutive growth capital, one of two things is true. Either the business does not actually carry itself, in which case the efficiency claim fails. Or the founders gave up equity they did not have to give up, in which case they are weak allocators of their own capital.
Capital need used to be neutral. Everyone had it. Today it is a signal, and it rarely points in the right direction.
Self-funding
Fees collected at closing. Subscriptions billed a year in advance. Prepaid usage. Costs settled monthly. The company holds the cash before it spends it, and every additional customer adds to that position rather than consuming it. Most of our theses work this way.
Where a business does carry receivables and supplier liabilities, the cycle can be turned around. Receivables are sold, so the money arrives at delivery instead of sixty days later. Supplier payment terms are extended, while suppliers keep the option to be paid early. The company collects before it pays.
Both produce the same result: the company funds its own growth. The second route runs through WALBING, and it applies to some of our theses and not to others. We say which.
The calculation
Take a company with 24 million euro in annual revenue, growing at 40 percent, with cost of goods at 60 percent of revenue.
| Component | Without WALBING | With WALBING |
|---|---|---|
| Receivables outstanding | 60 days | 3 days |
| Inventory | 30 days | 30 days |
| Payables outstanding | 30 days | 75 days |
| Cash conversion cycle | +60 days | −42 days |
0 %
Dilution. The liquidity comes from revenue, not from equity.
3 days
Receivables outstanding, down from sixty.
75 days
Payables outstanding, with suppliers still able to be paid early.
5.5 m€
Released, on these numbers. The size of a seed or Series A round.
In the first column the business ties up roughly 3.95 million euro, and each year of growth demands about 1.6 million more. In the second it releases roughly 1.58 million, and growth frees cash instead of consuming it.
The same growth curve that forces a financing round in the venture model pays for itself here.
These figures illustrate the mechanism. They are not a quote. What WALBING charges in a specific case depends on the creditworthiness of the debtors, the legal structure of the transaction, and the regulatory requirements that apply. Receivables are sold outright, which means the company is not borrowing and the receivable leaves its balance sheet. We show you the numbers for your business, in full, before you commit to anything.
Criteria
| Criterion | We prefer | We avoid |
|---|---|---|
| Domain | Financial services and the infrastructure underneath | Industries where we have no operating history |
| Scaling | Compute replaces headcount growth | Growth that needs people in proportion |
| Capital profile | Bootstrapped or capital-light | Structural dependence on burn |
| Revenue | Recurring, or billed in advance | Long pre-financed cycles |
| Working capital | Negative by pricing, or invertible | Capital tied up in assets or inventory |
| Founders | Efficiency and control | Growth at any price |
In biotech, in hardware, and in deep tech with heavy physical assets, pre-funded equity remains necessary. Compute does not replace a laboratory or a production line.
We state that boundary because it is what makes the rest of this testable rather than a belief. The argument holds where compute carries the scaling, and nowhere else.
We draw a second boundary ourselves. We build in financial services and the infrastructure underneath — payments, credit, treasury, compliance, capital markets. Outside that industry we have no operating history, no network and no WALBING, which means we would be offering money and little else. That is the thing we argue against.